Robert DeLuccia | Executive Chairman
Acurx Pharmaceuticals
Appearances:
Day 1 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 11:20
Presentation: Novel DNA pol IIIC Inhibitors for Gram-positive Bacterial Infections: Lead Product Candidate ibezapolstat Advancing to Phase 3 Trials
last published: 18/Apr/24 15:05 GMT
last published: 18/Apr/24 15:05 GMT
GET INVOLVED AT THE
WORLD ANTI-MICROBIAL RESISTANCE CONGRESS
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events